- জেনেরিক নাম
- Levetiracetam
- শক্তি
- 100 mg/ml
- ডোজ ফর্ম
- Suspension
- প্রস্তুতকারক
- Advanced Chemical Industries PLC
Citazar Suspension
Citazar 100 mg/ml Suspension সম্পর্কে
Citazar 100 mg/ml Suspension একটি সাসপেনশন ঔষধ, যার জেনেরিক নাম Levetiracetam এবং শক্তি ১০০ mg/ml। Citazar প্রস্তুত করেছে Advanced Chemical Industries PLC। Levetiracetam-এর অন্য ব্র্যান্ডগুলো এই পাতায় কম দাম থেকে সাজানো আছে, দাম তুলনা করতে পারবেন। ডাক্তারের প্রেসক্রিপশন মেনে চলুন এবং অন্য ব্র্যান্ড খাওয়া যাবে কি না তা ফার্মাসিস্টের কাছ থেকে জেনে নিন।
Levetiracetam-এর ৩৪টি ব্র্যান্ড বাংলাদেশে তালিকাভুক্ত। সবচেয়ে কম দাম Citazar 250 mg Tablet-এর, প্রতি ইউনিট ৳ ১৫.১১।
Citazar 100 mg/ml Suspension কী?
Citazar Suspension contains levetiracetam at a strength of 100 mg/ml and belongs to a group of medicines called adjunct anti-epileptic drugs. It works on the brain's electrical activity to help reduce the chance of seizures in people with epilepsy. It may be used alone in some newly diagnosed adults and adolescents, or alongside other epilepsy medicines in adults, adolescents, children and infants from one month of age, depending on the doctor's assessment. Epilepsy treatment is individual, so the doctor decides whether this medicine is suitable and how it should be used.
Citazar-এর ব্যবহার
Citazar is used in the treatment of partial-onset seizures, which may or may not spread to affect the whole body. In some adults and adolescents from sixteen years of age with newly diagnosed epilepsy, it can be used on its own. More often it is used together with other epilepsy medicines in adults, adolescents, children and infants from one month of age. Only a doctor can confirm whether it fits a person's type of epilepsy.
Citazar কীভাবে ব্যবহার করবেন
Citazar Suspension is swallowed as a liquid. Because it is a seizure medicine, the doctor decides the dose, how often it is given and how long treatment continues; do not change these yourself. Follow the doctor's instructions and the pharmacist's directions on the label. If a dose is missed or you are unsure about anything, ask the doctor or pharmacist rather than adjusting it yourself.
Citazar-এর পার্শ্বপ্রতিক্রিয়া
Some people may notice drowsiness, tiredness, infection or dizziness. In children, side effects can include tiredness, aggression, a blocked nose, reduced appetite and irritability. These are not the only possible effects. Tell the doctor or pharmacist if any side effect bothers you or does not settle, and seek medical help for anything severe or unexpected. Do not stop the medicine on your own.
সতর্কতা ও নিরাপত্তা
Do not use Citazar if there is a known allergy to levetiracetam, other pyrrolidone derivatives or any ingredient of the suspension. The doctor may need to adjust treatment in people with kidney problems or severe liver problems, and kidney function may be checked first. Levetiracetam is not recommended in pregnancy or in women who could become pregnant and are not using contraception unless the doctor considers it clinically necessary. It passes into breast milk, so breastfeeding is not recommended unless the doctor decides the benefits outweigh the risks. Tell the doctor about all other medicines you take, and ask the doctor first if you have any doubts.
সাধারণ প্রশ্ন
What is Citazar Suspension used for and what kind of medicine is it?
It is an adjunct anti-epileptic medicine containing levetiracetam. It is used for partial-onset seizures, either alone in some newly diagnosed adults and adolescents or together with other epilepsy medicines in a range of ages. The doctor decides if it is suitable.
How should Citazar Suspension be taken?
It is a liquid that is swallowed. The doctor decides the dose, how often it is taken and how long treatment lasts, so follow their instructions and the pharmacy label. Ask the doctor or pharmacist if you are unsure about anything, and do not change the dose yourself.
How should Citazar Suspension be stored?
Keep it in a cool, dry place away from light, at a temperature not above 25°C. Store it out of the reach of children. If you are unsure how to store it or what to do with unused medicine, ask your pharmacist.
Who should ask a doctor before using Citazar Suspension?
Ask the doctor first if you have kidney or liver problems, are pregnant or could become pregnant, or are breastfeeding, as levetiracetam is not recommended in these situations unless the doctor considers it necessary. Also tell the doctor about any allergy or other medicines you take.
নির্দেশনা
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Levetiracetam is indicated as monotherapy in the treatment of partial-onset seizures with or without secondary generalisation in adults and adolescents from 16 years of age with newly diagnosed epilepsy. Levetiracetam is indicated as adjunctive therapy-- in the treatment of partial-onset seizures with or without secondary generalization in adults, adolescents, children and infants from 1 month of age with epilepsy. ... Read more
- in the treatment of partial-onset seizures with or without secondary generalization in adults, adolescents, children and infants from 1 month of age with epilepsy.
- in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with Juvenile Myoclonic Epilepsy.
- in the treatment of primary generalized tonic-clonic seizures in adults and adolescents from 12 years of age with Idiopathic Generalised Epilepsy.
মাত্রা ও সেবনবিধি
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Adults and adolescents from 16 years of age: The recommended starting dose is 250 mg twice daily which should be increased to an initial therapeutic dose of 500 mg twice daily after two weeks. The dose can be further increased by 250 mg twice daily every two weeks depending upon the clinical response. The maximum dose is 1500 mg twice daily.Adults (≥18 years) and adolescents (12 to 17 years) weighing 50 kg or more: The initial therapeutic dose is 500 mg twice daily. This dose can be started on the first day of treatment. Depending upon the clinical response and tolerability, the daily dose can be increased up to 1,500 mg twice daily. Dose changes can be made in 500 mg twice daily increases or decrease every two to four weeks.
Pediatric population: The tablet formulation is not adapted for use in infants and children under the age of 6 years. Oral solution is the preferred formulation for use in this population. In addition, the available dose strengths of the tablets are not appropriate for initial treatment in children weighing less than 25 kg, for patients unable to swallow tablets or for the administration of doses below 250 mg. In all of the above cases, oral solution should be used.
- Monotherapy: The safety and efficacy of levetiracetam in children and adolescents below 16 years as monotherapy treatment have not been established.
- Add-on therapy: Oral solution is the preferred formulation for use in infants and children under the age of 6 years. For children 6 years and above, oral solution should be used for doses under 250 mg, for doses not in multiples of 250 mg when dosing recommendation is not achievable by taking multiple tablets and for patients unable to swallow tablets. The lowest effective dose should be used. The starting dose for a child or adolescent of 25 kg should be 250 mg twice daily with a maximum dose of 750 mg twice daily. Dosing for children 50 kg or greater is the same as in adults.
- Add-on therapy: For infants aged from 1 month to less than 6 months: The oral solution is the formulation to use in infants.
ঔষধের মিথষ্ক্রিয়া
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Antiepileptic medicinal products: Pre-marketing data from clinical studies conducted in adults indicate that levetiracetam did not influence the serum concentrations of existing antiepileptic medicinal products (phenytoin, carbamazepine, valproic acid, phenobarbital, lamotrigine, gabapentin and primidone) and that these antiepileptic medicinal products did not influence the pharmacokinetics of levetiracetam.Probenecid: Probenecid (500 mg four times daily), a renal tubular secretion blocking agent, has been shown to inhibit the renal clearance of the primary metabolite but not of levetiracetam. Nevertheless, the concentration of this metabolite remains low.
Methotrexate: Concomitant administration of levetiracetam and methotrexate has been reported to decrease methotrexate clearance, resulting in increased/prolonged blood methotrexate concentration to potentially toxic levels. Blood methotrexate and levetiracetam levels should be carefully monitored in patients treated concomitantly with the two drugs.
Laxatives: There have been isolated reports of decreased levetiracetam efficacy when the osmotic laxative macrogol has been concomitantly administered with oral levetiracetam. Therefore, macrogol should not be taken orally for one hour before and for one hour after taking levetiracetam.
Food and alcohol: The extent of absorption of levetiracetam was not altered by food, but the rate of absorption was slightly reduced. No data on the interaction of levetiracetam with alcohol are available.
প্রতিনির্দেশনা
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Hypersensitivity to the active substance or other pyrrolidone derivatives or to any of the excipients.পার্শ্ব প্রতিক্রিয়া
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Most common adverse reactions (incidence ≥ 5% more than placebo) include:- Adult patients: somnolence, asthenia, infection and dizziness
- Pediatric patients: fatigue, aggression, nasal congestion, decreased appetite, and irritability
গর্ভাবস্থায় ও স্তন্যদানকালে
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Levetiracetam is not recommended during pregnancy and in women of childbearing potential not using contraception unless clinically necessary. Levetiracetam is excreted in human breast milk. Therefore, breastfeeding is not recommended. However, if levetiracetam treatment is needed during breastfeeding, the benefit/risk of the treatment should be weighed considering the importance of breastfeeding. No impact on fertility was detected in animal studies. No clinical data are available, the potential risk for humans is unknown.সতর্কতা
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Renal impairment: The administration of levetiracetam to patients with renal impairment may require dose adjustment. In patients with severely impaired hepatic function, assessment of renal function is recommended before dose selection.Acute kidney injury: The use of levetiracetam has been very rarely associated with acute kidney injury with a time to onset ranging from a few days to several months.
Blood cell counts: Rare cases of decreased blood cell counts (neutropenia, agranulocytosis, leucopenia, thrombocytopenia and pancytopenia) have been described in association with levetiracetam administration, generally at the beginning of the treatment. Complete blood cell counts are advised in patients experiencing important weakness, pyrexia, recurrent infections or coagulation disorders.
Suicide: Suicide, suicide attempt, suicidal ideation and behaviour have been reported in patients treated with anti-epileptic agents (including levetiracetam). A meta-analysis of randomized placebo-controlled trials of anti-epileptic medicinal products has shown a small increased risk of suicidal thoughts and behaviour. The mechanism of this risk is not known. Therefore patients should be monitored for signs of depression and/or suicidal ideation and behaviours and appropriate treatment should be considered. Patients (and caregivers of patients) should be advised to seek medical advice should signs of depression and/or suicidal ideation or behaviour emerge.
Paediatric population: The tablet formulation is not adapted for use in infants and children under the age of 6 years. Available data in children did not suggest an impact on growth and puberty. However, long term effects on learning, intelligence, growth, endocrine function, puberty and childbearing potential in children remain unknown.
মাত্রাধিক্যতা
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Somnolence, agitation, aggression, depressed level of consciousness, respiratory depression and coma were observed with levetiracetam overdoses. After an acute overdose, the stomach may be emptied by gastric lavage or by induction of emesis. There is no specifc antidote for levetiracetam. Treatment of an overdose will be symptomatic and may include haemodialysis. The dialyser extraction efficiency is 60 % for levetiracetam and 74% for the primary metabolite.সংরক্ষণ
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Store at a cool temperature (not exceeding 25°C) and dry place, protected from light.বিকল্প ব্র্যান্ড: Levetiracetam
একই জেনেরিকের অন্য ব্র্যান্ড, কম দাম আগে।
ঔষধের তথ্য শুধু জানার জন্য, এটি চিকিৎসা পরামর্শ নয়। সবসময় ডাক্তারের প্রেসক্রিপশন মানুন এবং ফার্মাসিস্টের সাথে কথা বলুন।